Adoption of Accounting Pronouncement (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
| Accounting Policies [Abstract] |
|
| Schedule of Future Policy Benefits and Changes to the Liability |
The following table summarizes future policy benefits and changes to the liability:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In millions) | Traditional deferred annuities | | Indexed annuities | | Payout annuities | | Reconciling items1 | | Total | | Balance as of January 1, 2022 | $ | 221 | | | $ | 5,389 | | | $ | 32,872 | | | $ | 8,632 | | | $ | 47,114 | | | Change in discount rate assumptions | — | | | — | | | 2,406 | | | — | | | 2,406 | | | Adjustment for removal of balances related to market risk benefits | (221) | | | (5,389) | | | — | | | — | | | (5,610) | | Adjustment for offsetting balance in negative VOBA2 | — | | | — | | | — | | | (2,428) | | | (2,428) | | | Adjusted balance as of January 1, 2022 | $ | — | | | $ | — | | | $ | 35,278 | | | $ | 6,204 | | | $ | 41,482 | | | | | | | | | | | | 1 Reconciling items primarily include negative VOBA associated with our liability for future policy benefits, as well as reserves for our immaterial lines of business including term and whole life, accident and health and disability, as well as other insurance benefit reserves for our no-lapse guarantees with universal life contracts, all of which are fully ceded. | 2 Uneliminated adjustments were recorded to positive VOBA within deferred acquisition costs, deferred sales inducements and value of business acquired on the consolidated statements of financial condition. |
The following is a rollforward by product within future policy benefits:
| | | | | | | | | | | | | | | | | | | Year ended December 31, 2023 | | (In millions, except percentages and years) | Payout annuities with life contingencies | | Whole life | | Total | | Present value of expected net premiums | | | | | | | Beginning balance | $ | — | | | $ | — | | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Issuances | — | | | 3,091 | | | 3,091 | | | Interest accrual | — | | | 6 | | | 6 | | | Net premium collected | — | | | (2,027) | | | (2,027) | | | Foreign exchange | — | | | 65 | | | 65 | | | Ending balance at original discount rate | — | | | 1,135 | | | 1,135 | | | Effect of changes in discount rate assumptions | — | | | 45 | | | 45 | | | Effect of foreign exchange on the change in discount rate assumptions | — | | | 2 | | | 2 | | | Ending balance | $ | — | | | $ | 1,182 | | | $ | 1,182 | | | Present value of expected future policy benefits | | | | | | Beginning balance | $ | 36,422 | | | $ | — | | | $ | 36,422 | | | Effect of changes in discount rate assumptions | 8,425 | | | — | | | 8,425 | | | Effect of foreign exchange on the change in discount rate assumptions | (13) | | | — | | | (13) | | | Beginning balance at original discount rate | 44,834 | | | — | | | 44,834 | | | Effect of changes in cash flow assumptions | (297) | | | — | | | (297) | | | Effect of actual experience to expected experience | (67) | | | — | | | (67) | | | Adjusted balance | 44,470 | | | — | | | 44,470 | | | Issuances | 10,427 | | | 3,091 | | | 13,518 | | | Interest accrual | 1,646 | | | 18 | | | 1,664 | | | Benefit payments | (3,834) | | | (18) | | | (3,852) | | | Foreign exchange | 35 | | | 185 | | | 220 | | Other1 | (1,509) | | | — | | | (1,509) | | | Ending balance at original discount rate | 51,235 | | | 3,276 | | | 54,511 | | | Effect of changes in discount rate assumptions | (6,233) | | | 89 | | | (6,144) | | | Effect of foreign exchange on the change in discount rate assumptions | (1) | | | 6 | | | 5 | | | Ending balance | $ | 45,001 | | | $ | 3,371 | | | $ | 48,372 | | | | | | | | | Net future policy benefits | $ | 45,001 | | | $ | 2,189 | | | $ | 47,190 | | | | | | | | | | | | | | | | | | | | | | Weighted-average liability duration (in years) | 9.5 | | 33.5 | | | | Weighted-average interest accretion rate | 3.6 | % | | 4.8 | % | | | | Weighted-average current discount rate | 5.1 | % | | 4.1 | % | | | | Expected future gross premiums, undiscounted | $ | — | | | $ | 1,497 | | | | Expected future gross premiums, discounted2 | — | | | 1,239 | | | | | Expected future benefit payments, undiscounted | 75,261 | | | 11,344 | | | | | | | | | | 1 Other represents a $1,509 million reduction of reserves related to the VIAC recapture agreement. See note 19 for further information. | 2 Discounted at the original discount rate. |
| | | | | | | | | | | | | | | | | | | Year ended December 31, 2022 | | (In millions, except percentages and years) | Payout annuities with life contingencies | | Whole life | | Total | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Present value of expected future policy benefits | | | | | | | Beginning balance | $ | 35,278 | | | $ | — | | | $ | 35,278 | | | Effect of changes in discount rate assumptions | — | | | — | | | — | | | | | | | | | Beginning balance at original discount rate | 35,278 | | | — | | | 35,278 | | | | | | | | | Effect of actual experience to expected experience | (120) | | | — | | | (120) | | | Adjusted balance | 35,158 | | | — | | | 35,158 | | | Issuances | 11,528 | | | — | | | 11,528 | | | Interest accrual | 1,146 | | | — | | | 1,146 | | | Benefit payments | (2,921) | | | — | | | (2,921) | | | Foreign exchange | (77) | | | — | | | (77) | | | | | | | | | Ending balance at original discount rate | 44,834 | | | — | | | 44,834 | | | Effect of changes in discount rate assumptions | (8,425) | | | — | | | (8,425) | | | Effect of foreign exchange on the change in discount rate assumptions | 13 | | | — | | | 13 | | | Ending balance | $ | 36,422 | | | $ | — | | | $ | 36,422 | | | | | | | | | Net future policy benefits | $ | 36,422 | | | $ | — | | | $ | 36,422 | | | | | | | | | | | | | | | | | | | | | | Weighted-average liability duration (in years) | 10.2 | | 0.0 | | | | Weighted-average interest accretion rate | 3.2 | % | | — | % | | | | Weighted-average current discount rate | 5.5 | % | | — | % | | | | | | | | | | | | | | | | Expected future benefit payments, undiscounted | $ | 64,754 | | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The following is a reconciliation of future policy benefits to the consolidated statements of financial condition:
| | | | | | | | | | | | | December 31, | | (In millions) | 2023 | | 2022 | | Payout annuities with life contingencies | $ | 45,001 | | | $ | 36,422 | | | Whole life | 2,189 | | | — | | Reconciling items1 | 6,097 | | | 5,688 | | | Future policy benefits | $ | 53,287 | | | $ | 42,110 | | | | | | 1 Reconciling items primarily include the deferred profit liability and negative VOBA associated with the liability for future policy benefits. Additionally, it includes term life reserves, fully ceded whole life reserves, and reserves for immaterial lines of business including accident and health and disability, as well as other insurance benefit reserves for no-lapse guarantees with universal life contracts, all of which are fully ceded. |
The following is a reconciliation of premiums and interest expense relating to future policy benefits to the consolidated statements of operations:
| | | | | | | | | | | | | | | | | | | | | | | | | Premiums | | Interest expense | | Years ended December 31, | | Years ended December 31, | | (In millions) | 2023 | | 2022 | | 2023 | | 2022 | | Payout annuities with life contingencies | $ | 10,504 | | | $ | 11,606 | | | $ | 1,646 | | | $ | 1,146 | | | Whole life | 2,214 | | | — | | | 12 | | | — | | Reconciling items1 | 31 | | | 32 | | | — | | | — | | | Total | $ | 12,749 | | | $ | 11,638 | | | $ | 1,658 | | | $ | 1,146 | | | | | | | | | | 1 Reconciling items primarily relate to immaterial lines of business including term life, fully ceded whole life, and accident and health and disability. |
The following is a summary of remeasurement gains (losses) included within future policy and other policy benefits on the consolidated statements of operations:
| | | | | | | | | | | | | Years ended December 31, | | (In millions) | 2023 | | 2022 | | Reserves | $ | 364 | | | $ | 120 | | | Deferred profit liability | (246) | | | (126) | | | Negative VOBA | (65) | | | 21 | | | Total remeasurement gains (losses) | $ | 53 | | | $ | 15 | |
|
| Schedule of Net Liability Position of Market Risk Benefits |
The following table presents the net liability position of market risk benefits:
| | | | | | | | | | | | | | | | | | | (In millions) | Traditional deferred annuities | | Indexed annuities | | Total | | Balance as of January 1, 2022 | $ | — | | | $ | — | | | $ | — | | Adjustment for addition of existing balances1 | 221 | | | 5,389 | | | 5,610 | | Adjustment to positive VOBA due to fair value adjustment for market risk benefits2 | 32 | | | (1,165) | | | (1,133) | | Adjustment to negative VOBA due to fair value adjustment for market risk benefits3 | — | | | (30) | | | (30) | | | Adjusted balance as of January 1, 2022 | $ | 253 | | | $ | 4,194 | | | $ | 4,447 | | | | | | | | 1 Previously recorded within future policy benefits on the consolidated statements of financial condition. | 2 Previously recorded within deferred acquisition costs, deferred sales inducements and value of business acquired on the consolidated statements of financial condition. | 3 Previously recorded within interest sensitive contract liabilities on the consolidated statements of financial condition. |
The following table represents market risk benefits by asset and liability positions:
| | | | | | | | | | | | | | | | | | | (In millions) | Asset1 | | Liability | | Net liability | | Traditional deferred annuities | $ | — | | | $ | 253 | | | $ | 253 | | | Indexed annuities | 366 | | | 4,560 | | | 4,194 | | | Adjusted balance as of January 1, 2022 | $ | 366 | | | $ | 4,813 | | | $ | 4,447 | | | | | | | | 1 Included within other assets on the consolidated statements of financial condition. |
The following is a rollfoward of net market risk benefit liabilities by product:
| | | | | | | | | | | | | | | | | | | | | Year ended December 31, 2023 | | (In millions) | Traditional deferred annuities | | Indexed annuities | | | | Total | Balance at December 31, 2022 | $ | 170 | | | $ | 2,319 | | | | | $ | 2,489 | | | Effect of changes in instrument-specific credit risk | 13 | | | 353 | | | | | 366 | | | Balance, beginning of period, before changes in instrument-specific credit risk | 183 | | | 2,672 | | | | | 2,855 | | | Issuances | — | | | 106 | | | | | 106 | | | Interest accrual | 10 | | | 147 | | | | | 157 | | | Attributed fees collected | 2 | | | 336 | | | | | 338 | | | Benefit payments | (2) | | | (32) | | | | | (34) | | | Effect of changes in interest rates | (1) | | | (90) | | | | | (91) | | | Effect of changes in equity | — | | | (119) | | | | | (119) | | | Effect of actual policyholder behavior compared to expected behavior | 5 | | | 67 | | | | | 72 | | | Effect of changes in future expected policyholder behavior | (3) | | | 78 | | | | | 75 | | | Effect of changes in other future expected assumptions | — | | | 6 | | | | | 6 | | | Balance, end of period, before changes in instrument-specific credit risk | 194 | | | 3,171 | | | | | 3,365 | | | Effect of changes in instrument-specific credit risk | (2) | | | 10 | | | | | 8 | | Balance at December 31, 2023 | $ | 192 | | | $ | 3,181 | | | | | $ | 3,373 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net amount at risk | $ | 425 | | | $ | 14,716 | | | | | | Weighted-average attained age of contract holders (in years) | 75 | | 69 | | | | |
| | | | | | | | | | | | | | | | | | | | | Year ended December 31, 2022 | | (In millions) | Traditional deferred annuities | | Indexed annuities | | | | Total | | Balance at January 1, 2022 | $ | 253 | | | $ | 4,194 | | | | | $ | 4,447 | | | | | | | | | | | | | | | | | | | Issuances | — | | | 60 | | | | | 60 | | | Interest accrual | 4 | | | 52 | | | | | 56 | | | Attributed fees collected | 3 | | | 330 | | | | | 333 | | | Benefit payments | (4) | | | (49) | | | | | (53) | | | Effect of changes in interest rates | (77) | | | (2,092) | | | | | (2,169) | | | Effect of changes in equity | — | | | 176 | | | | | 176 | | | Effect of actual policyholder behavior compared to expected behavior | 6 | | | 42 | | | | | 48 | | | | | | | | | | | Effect of changes in other future expected assumptions | (2) | | | (41) | | | | | (43) | | | Balance, end of period, before changes in instrument-specific credit risk | 183 | | | 2,672 | | | | | 2,855 | | | Effect of changes in instrument-specific credit risk | (13) | | | (353) | | | | | (366) | | Balance at December 31, 2022 | $ | 170 | | | $ | 2,319 | | | | | $ | 2,489 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net amount at risk | $ | 422 | | | $ | 13,581 | | | | | | Weighted-average attained age of contract holders (in years) | 74 | | 68 | | | | |
|
| Schedule of Change in Deferred Acquisition Costs and Value of Business Acquired |
The following table summarizes the change in deferred acquisition costs, deferred sales inducements and value of business acquired:
| | | | | | | (In millions) | VOBA | | Balance as of January 1, 2022 | $ | 4,527 | | | Change in discount rate assumptions for future policy benefits | (22) | | | Fair value adjustment of market risk benefits | (1,133) | | | Adjusted balance as of January 1, 2022 | $ | 3,372 | |
The following represents a rollforward of DAC and DSI by product, and a rollforward of VOBA. See note 12 for more information on Athene’s products.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | DAC | | DSI | | VOBA | | Total DAC, DSI and VOBA | | (In millions) | Traditional deferred annuities | | Indexed annuities | | Funding agreements | | Other investment-type | | Indexed annuities | | | | Balance at January 1, 2022 | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | 3,372 | | | $ | 3,372 | | | Additions | 320 | | | 784 | | | 14 | | | 9 | | | 411 | | | — | | | 1,538 | | | | | | | | | | | | | | | | | Amortization | (16) | | | (29) | | | (3) | | | — | | | (12) | | | (384) | | | (444) | | Balance at December 31, 2022 | 304 | | | 755 | | | 11 | | | 9 | | | 399 | | | 2,988 | | | 4,466 | | | Additions | 701 | | | 863 | | | 3 | | | 3 | | | 634 | | | — | | | 2,204 | | | | | | | | | | | | | | | | | Amortization | (115) | | | (101) | | | (4) | | | (1) | | | (63) | | | (404) | | | (688) | | | Other | — | | | — | | | — | | | — | | | — | | | (3) | | | (3) | | Balance at December 31, 2023 | $ | 890 | | | $ | 1,517 | | | $ | 10 | | | $ | 11 | | | $ | 970 | | | $ | 2,581 | | | $ | 5,979 | |
|
| Schedule of Deferred Sales Inducements |
The following table summarizes the change in deferred acquisition costs, deferred sales inducements and value of business acquired:
| | | | | | | (In millions) | VOBA | | Balance as of January 1, 2022 | $ | 4,527 | | | Change in discount rate assumptions for future policy benefits | (22) | | | Fair value adjustment of market risk benefits | (1,133) | | | Adjusted balance as of January 1, 2022 | $ | 3,372 | |
The following represents a rollforward of DAC and DSI by product, and a rollforward of VOBA. See note 12 for more information on Athene’s products.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | DAC | | DSI | | VOBA | | Total DAC, DSI and VOBA | | (In millions) | Traditional deferred annuities | | Indexed annuities | | Funding agreements | | Other investment-type | | Indexed annuities | | | | Balance at January 1, 2022 | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | 3,372 | | | $ | 3,372 | | | Additions | 320 | | | 784 | | | 14 | | | 9 | | | 411 | | | — | | | 1,538 | | | | | | | | | | | | | | | | | Amortization | (16) | | | (29) | | | (3) | | | — | | | (12) | | | (384) | | | (444) | | Balance at December 31, 2022 | 304 | | | 755 | | | 11 | | | 9 | | | 399 | | | 2,988 | | | 4,466 | | | Additions | 701 | | | 863 | | | 3 | | | 3 | | | 634 | | | — | | | 2,204 | | | | | | | | | | | | | | | | | Amortization | (115) | | | (101) | | | (4) | | | (1) | | | (63) | | | (404) | | | (688) | | | Other | — | | | — | | | — | | | — | | | — | | | (3) | | | (3) | | Balance at December 31, 2023 | $ | 890 | | | $ | 1,517 | | | $ | 10 | | | $ | 11 | | | $ | 970 | | | $ | 2,581 | | | $ | 5,979 | |
|
| Schedule of Statement of Financial Condition, Statements of Income (Loss), Statements of Comprehensive Income (Loss), Statements of Cash Flows |
The following represents the effects of LDTI adoption on the applicable financial statement lines of the Company’s consolidated statement of financial condition:
| | | | | | | | | | | | | | | | | | | As of December 31, 2022 | | (In millions) | Reported | | Adoption | | Adjusted | | Assets | | | | | | | Retirement Services | | | | | | | Reinsurance recoverable | $ | 4,367 | | | $ | (9) | | | $ | 4,358 | | | Deferred acquisition costs, deferred sales inducements and value of business acquired | 5,576 | | | (1,110) | | | 4,466 | | | Other assets | 10,902 | | | (997) | | | 9,905 | | | | | | | | | Total Assets | $ | 259,333 | | | $ | (2,116) | | | $ | 257,217 | | | | | | | | | Liabilities and Equity | | | | | | | Liabilities | | | | | | | Retirement Services | | | | | | | Interest sensitive contract liabilities | $ | 173,653 | | | $ | (37) | | | $ | 173,616 | | | Future policy benefits | 55,328 | | | (13,218) | | | 42,110 | | | Market risk benefits | — | | | 2,970 | | | 2,970 | | | | | | | | | Total Liabilities | 252,104 | | | (10,285) | | | 241,819 | | | Equity | | | | | | | Retained earnings (accumulated deficit) | (2,259) | | | 1,252 | | | (1,007) | | | Accumulated other comprehensive income (loss) | (12,326) | | | 4,991 | | | (7,335) | | | Total Apollo Global Management, Inc. Stockholders’ Equity | 397 | | | 6,243 | | | 6,640 | | | Non-controlling interests | 5,800 | | | 1,926 | | | 7,726 | | | Total Equity | 6,197 | | | 8,169 | | | 14,366 | | | Total Liabilities, Redeemable non-controlling interests and Equity | $ | 259,333 | | | $ | (2,116) | | | $ | 257,217 | |
The following represents the effects of LDTI adoption on the applicable financial statement lines of the Company’s consolidated statements of operations:
| | | | | | | | | | | | | | | | | | | Year ended December 31, 2022 | | (In millions, except per share data) | Reported | | Adoption | | Adjusted | | | | | | | | | | | | | | | | | | | | | | | | | | Total Revenues | $ | 10,968 | | | $ | — | | | $ | 10,968 | | | Expenses | | | | | | | Retirement Services | | | | | | | Interest sensitive contract benefits | 541 | | | (3) | | | 538 | | | Future policy and other policy benefits | 12,310 | | | 155 | | | 12,465 | | | Market risk benefits remeasurement (gains) losses | — | | | (1,657) | | | (1,657) | | | Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired | 509 | | | (65) | | | 444 | | | Policy and other operating expenses | 1,371 | | | 1 | | | 1,372 | | | | | | | | | Total Expenses | 17,480 | | | (1,569) | | | 15,911 | | | Income (loss) before income tax (provision) benefit | (5,815) | | | 1,569 | | | (4,246) | | | Income tax (provision) benefit | 1,069 | | | (330) | | | 739 | | | Net income (loss) | (4,746) | | | 1,239 | | | (3,507) | | | Net (income) loss attributable to non-controlling interests | 1,533 | | | 13 | | | 1,546 | | | Net income (loss) attributable to Apollo Global Management, Inc. common stockholders | $ | (3,213) | | | $ | 1,252 | | | $ | (1,961) | | | | | | | | | Earnings (loss) per share | | | | | | | Net income (loss) attributable to common stockholders - Basic and Diluted | $ | (5.57) | | | $ | 2.14 | | | $ | (3.43) | |
The following represents the effects of LDTI adoption on the applicable financial statement lines of the Company’s consolidated statements of comprehensive income (loss):
| | | | | | | | | | | | | | | | | | | Year ended December 31, 2022 | | (In millions) | Reported | | Adoption | | Adjusted | | Net income (loss) | $ | (4,746) | | | $ | 1,239 | | | $ | (3,507) | | | Other comprehensive income (loss), before tax | | | | | | | Unrealized investment gains (losses) on available-for-sale securities | (17,459) | | | (699) | | | (18,158) | | | | | | | | | Remeasurement gains (losses) on future policy benefits related to discount rate | — | | | 8,425 | | | 8,425 | | | Remeasurement gains (losses) on market risk benefits related to credit risk | — | | | 366 | | | 366 | | | Foreign currency translation and other adjustments | (46) | | | (12) | | | (58) | | | Other comprehensive income (loss), before tax | (17,501) | | | 8,080 | | | (9,421) | | | Income tax expense (benefit) related to other comprehensive income (loss) | (3,083) | | | 1,150 | | | (1,933) | | | Other comprehensive income (loss) | (14,418) | | | 6,930 | | | (7,488) | | | Comprehensive income (loss) | (19,164) | | | 8,169 | | | (10,995) | | | Comprehensive (income) loss attributable to non-controlling interests | 3,630 | | | (1,926) | | | 1,704 | | | Comprehensive income (loss) attributable to Apollo Global Management, Inc. | $ | (15,534) | | | $ | 6,243 | | | $ | (9,291) | |
The Company made corresponding adjustments to the consolidated statements of equity to reflect the changes to net income (loss) and comprehensive income (loss), as presented above.
The following represents the effects of LDTI adoption on the applicable financial statement lines of the Company’s consolidated statements of cash flows:
| | | | | | | | | | | | | | | | | | | Year ended December 31, 2022 | | (In millions) | Reported | | Adoption | | Adjusted | | Net income (loss) | $ | (4,746) | | | $ | 1,239 | | | $ | (3,507) | | | Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | | | | | | Depreciation and amortization | 594 | | | (65) | | | 529 | | | Changes in operating assets and liabilities: | | | | | | | Interest sensitive contract liabilities | (1,269) | | | (68) | | | (1,337) | | | Future policy benefits, market risk benefits and reinsurance recoverable | 5,339 | | | (1,438) | | | 3,901 | | | Other assets and liabilities | 3,049 | | | 332 | | | 3,381 | | | Net cash provided by operating activities | 3,789 | | | — | | | 3,789 | | | Net cash used in investing activities | (23,444) | | | — | | | (23,444) | | | Net cash provided by financing activities | 28,710 | | | — | | | 28,710 | | | Effect of exchange rate changes on cash and cash equivalents | (15) | | | — | | | (15) | | | Net increase in cash and cash equivalents, restricted cash and cash equivalents, and cash and cash equivalents held at consolidated variable interest entities | 9,040 | | | — | | | 9,040 | | | Cash and cash equivalents, restricted cash and cash equivalents, and cash and cash equivalents held at consolidated variable interest entities, Beginning of Period | 2,088 | | | — | | | 2,088 | | | Cash and cash equivalents, restricted cash and cash equivalents, and cash and cash equivalents held at consolidated variable interest entities, End of Period | $ | 11,128 | | | $ | — | | | $ | 11,128 | | | | | | | | |
|